TERMINATION AGREEMENT

EX-10.2 5 v31294exv10w2.htm EXHIBIT 10.2 exv10w2
 

EXHIBIT 10.2
TERMINATION AGREEMENT
     This TERMINATION AGREEMENT is entered into and effective as of June 22, 2007.
RECITALS:
     WHEREAS, the parties hereto are parties to that certain Amended and Restated Recapitalization Agreement dated as of July 30, 2004 by and between the Company and Toucan Capital, as amended October 22, 2004, November 10, 2004, December 27, 2004, January 26, 2005, April 12, 2005, May 13, 2005, June 16, 2005, July 26, 2005, September 7, 2005 and November 14, 2005 (the “Recapitalization Agreement”).
     WHEREAS, the parties to the Recapitalization Agreement now desire to terminate the Recapitalization Agreement, subject to the survival of certain provisions thereof.
AGREEMENTS:
     NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:
     1. Each of the Company and Toucan Capital hereby terminate the Recapitalization Agreement. Each party acknowledges that there shall be no further obligations under the Recapitalization Agreement following the date hereof other than (a) rights related to breaches of the Recapitalization Agreement occurring prior to the date hereof, and (b) the following provisions: (i) Section 4.4 (Indemnification), (ii) Section 4.5 (Injunctive Relief), and (iii) Section 4.13 (Miscellaneous).
     2. This Termination may be executed in one or more counterparts, each of which shall be deemed an original but all of which taken together shall constitute one and the same instrument.
[Signature Page Follows]

 


 

     IN WITNESS WHEREOF, each of the parties hereto has executed this Termination Agreement as of the date set forth above.
                     
Northwest Biotherapeutics, Inc.       Toucan Capital Fund II, L.P.    
 
                   
By:
          By:        
 
                   
 
       Alton Boynton                Linda F. Powers    
 
            President                Managing Director    
 
                   
 
       Address:                 Address:    
 
                   
 
       Northwest Biotherapeutics, Inc.                Linda F. Powers    
 
       Attention: Alton Boynton                Managing Director    
 
       18701 120th Avenue, NE,                Toucan Capital Corp.    
 
       Suite 101                7600 Wisconsin Ave, 7th Floor    
 
       Bothell, Washington 98011                Bethesda, MD 20814    
 
       Facsimile: 425 ###-###-####                Facsimile: 240 ###-###-####    
 
                   E-Mail ***@***    
 
                   
            Toucan Partners, LLC    
 
                   
 
          By:        
 
                   
 
                   Linda F. Powers    
 
                   Managing Member    
 
                   
 
                   Address:    
 
                   
 
                   Toucan Partners, LLC    
 
                   7600 Wisconsin Avenue    
 
                   Suite 700    
 
                   Bethesda, MD 20814    
 
                   Facsimile: 240 ###-###-####    
 
                   E-Mail ***@***